The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
Backgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combin...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8736509 |
id |
doaj-1fe6e4441ed4413d8536d72e478b6c5a |
---|---|
record_format |
Article |
spelling |
doaj-1fe6e4441ed4413d8536d72e478b6c5a2020-11-25T01:44:36ZengHindawi LimitedDisease Markers0278-02401875-86302020-01-01202010.1155/2020/87365098736509The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-AnalysisErhu Fang0Xiaolin Wang1Jiexiong Feng2Xiang Zhao3Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaBackgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combination of CRP and ALB, we conducted a meta-analysis to evaluate the prognostic role of these two parameters for sarcoma patients. Methods. A detailed literature search was conducted in MEDLINE, Embase, and Cochrane Library for relevant research publications written in English. Patients’ clinical characteristics, outcomes of overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were extracted. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to evaluate the prognostic role of GPS or CAR. Results. Twelve articles containing 2695 patients were identified as eligible studies. The results showed that an elevated GPS was significantly correlated with poor OS (HR=2.42; 95% CI: 1.98-2.94; p<0.001; fixed-effects model), DSS (HR=2.28; 95% CI: 1.75-2.97; p<0.001; fixed-effects model), and DFS (HR=2.05; 95% CI: 1.62-2.60; p<0.001; fixed-effects model). A higher CAR also was shown to be significantly correlated with poor OS (HR=2.23; 95% CI: 1.70-2.92; p<0.001; fixed-effects model) and DFS (HR=1.81; 95% CI: 1.7-2.58; p=0.001; fixed-effects model). Conclusion. An elevated GPS is predictive of poor survival in patients with sarcomas and is promising to be used as a factor for risk stratification. A higher CAR value is also predictive of poor survival; however, the optimal CAR cut-off value is still to be determined.http://dx.doi.org/10.1155/2020/8736509 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Erhu Fang Xiaolin Wang Jiexiong Feng Xiang Zhao |
spellingShingle |
Erhu Fang Xiaolin Wang Jiexiong Feng Xiang Zhao The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis Disease Markers |
author_facet |
Erhu Fang Xiaolin Wang Jiexiong Feng Xiang Zhao |
author_sort |
Erhu Fang |
title |
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis |
title_short |
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis |
title_full |
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis |
title_fullStr |
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis |
title_full_unstemmed |
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis |
title_sort |
prognostic role of glasgow prognostic score and c-reactive protein to albumin ratio for sarcoma: a system review and meta-analysis |
publisher |
Hindawi Limited |
series |
Disease Markers |
issn |
0278-0240 1875-8630 |
publishDate |
2020-01-01 |
description |
Backgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combination of CRP and ALB, we conducted a meta-analysis to evaluate the prognostic role of these two parameters for sarcoma patients. Methods. A detailed literature search was conducted in MEDLINE, Embase, and Cochrane Library for relevant research publications written in English. Patients’ clinical characteristics, outcomes of overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were extracted. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to evaluate the prognostic role of GPS or CAR. Results. Twelve articles containing 2695 patients were identified as eligible studies. The results showed that an elevated GPS was significantly correlated with poor OS (HR=2.42; 95% CI: 1.98-2.94; p<0.001; fixed-effects model), DSS (HR=2.28; 95% CI: 1.75-2.97; p<0.001; fixed-effects model), and DFS (HR=2.05; 95% CI: 1.62-2.60; p<0.001; fixed-effects model). A higher CAR also was shown to be significantly correlated with poor OS (HR=2.23; 95% CI: 1.70-2.92; p<0.001; fixed-effects model) and DFS (HR=1.81; 95% CI: 1.7-2.58; p=0.001; fixed-effects model). Conclusion. An elevated GPS is predictive of poor survival in patients with sarcomas and is promising to be used as a factor for risk stratification. A higher CAR value is also predictive of poor survival; however, the optimal CAR cut-off value is still to be determined. |
url |
http://dx.doi.org/10.1155/2020/8736509 |
work_keys_str_mv |
AT erhufang theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT xiaolinwang theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT jiexiongfeng theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT xiangzhao theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT erhufang prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT xiaolinwang prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT jiexiongfeng prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis AT xiangzhao prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis |
_version_ |
1715678360413143040 |